Systems biology approaches to understanding stem cell fate choice
- PMID: 20001088
- DOI: 10.1049/iet-syb.2009.0011
Systems biology approaches to understanding stem cell fate choice
Abstract
Stem cells have the capability to self-renew and maintain their undifferentiated state or to differentiate into one or more specialised cell types. Stem cell expansion and manipulation ex vivo is a promising approach for engineering cell replacement therapies, and endogenous stem cells represent potential drugable targets for tissue repair. Before we can harness stem cells' therapeutic potential, we must first understand the intracellular mechanisms controlling their fate choices. These mechanisms involve complex signal transduction and gene regulation networks that feature, for example, intricate feed-forward loops, feedback loops and cross-talk between multiple signalling pathways. Systems biology applies computational and experimental approaches to investigate the emergent behaviour of collections of molecules and strives to explain how these numerous components interact to regulate molecular, cellular and organismal behaviour. Here we review systems biology, and in particular computational, efforts to understand the intracellular mechanisms of stem cell fate choice. We first discuss deterministic and stochastic models that synthesise molecular knowledge into mathematical formalism, enable simulation of important system behaviours and stimulate further experimentation. In addition, statistical analyses such as Bayesian networks and principal components analysis (PCA)/partial least squares (PLS) regression can distill large datasets into more readily managed networks and principal components that provide insights into the critical aspects and components of regulatory networks. Collectively, integrating modelling with experimentation has strong potential for enabling a deeper understanding of stem cell fate choice and thereby aiding the development of therapies to harness stem cells' therapeutic potential.
Similar articles
-
The biology and engineering of stem-cell control.Biotechnol Appl Biochem. 2004 Aug;40(Pt 1):5-16. doi: 10.1042/BA20030195. Biotechnol Appl Biochem. 2004. PMID: 15270702 Review.
-
Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.Trends Pharmacol Sci. 2010 Jan;31(1):36-45. doi: 10.1016/j.tips.2009.10.002. Epub 2009 Nov 4. Trends Pharmacol Sci. 2010. PMID: 19896224 Review.
-
Gene regulatory network inference: data integration in dynamic models-a review.Biosystems. 2009 Apr;96(1):86-103. doi: 10.1016/j.biosystems.2008.12.004. Epub 2008 Dec 27. Biosystems. 2009. PMID: 19150482 Review.
-
Quantitative stem cell biology: computational studies in the hematopoietic system.Curr Opin Hematol. 2006 Jul;13(4):222-8. doi: 10.1097/01.moh.0000231418.08031.48. Curr Opin Hematol. 2006. PMID: 16755217 Review.
-
Intimate relationships with their neighbors: tales of stem cells in Drosophila reproductive systems.Dev Dyn. 2005 Mar;232(3):775-90. doi: 10.1002/dvdy.20317. Dev Dyn. 2005. PMID: 15704119 Review.
Cited by
-
Network based meta-analysis prediction of microenvironmental relays involved in stemness of human embryonic stem cells.PeerJ. 2014 Oct 23;2:e618. doi: 10.7717/peerj.618. eCollection 2014. PeerJ. 2014. PMID: 25374775 Free PMC article.
-
Functions and roles of proteins: diabetes as a paradigm.Prog Biophys Mol Biol. 2014 Jan;114(1):2-7. doi: 10.1016/j.pbiomolbio.2013.11.003. Epub 2013 Nov 13. Prog Biophys Mol Biol. 2014. PMID: 24239502 Free PMC article. Review.
-
Probing the role of stochasticity in a model of the embryonic stem cell: heterogeneous gene expression and reprogramming efficiency.BMC Syst Biol. 2012 Aug 13;6:98. doi: 10.1186/1752-0509-6-98. BMC Syst Biol. 2012. PMID: 22889237 Free PMC article.
-
Dynamic network biomarker C1QTNF1 regulates tumor formation at the tipping point of hepatocellular carcinoma.Biomol Biomed. 2024 Mar 16;24(4):939-951. doi: 10.17305/bb.2024.10103. Biomol Biomed. 2024. PMID: 38498315 Free PMC article.
-
Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche.Integr Biol (Camb). 2020 Jul 10;12(7):175-187. doi: 10.1093/intbio/zyaa013. Integr Biol (Camb). 2020. PMID: 32556172 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical